Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Merck would provide between $2.75-$4 million in the first year in R&D funding, with up to $25 million in additional funding contingent on the achievement of
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury